InterOcean Capital Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

InterOcean Capital Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,000	Closed	-$15.1K	–	462
2022 Q4	$15.1K	Hold	17,000	–	–	﹤0.01%	398
2022 Q3	$27K	Hold	17,000	–	–	﹤0.01%	406
2022 Q2	$34K	Hold	17,000	–	–	﹤0.01%	418
2022 Q1	$40K	Hold	17,000	–	–	﹤0.01%	282
2021 Q4	$79K	Buy	17,000 +3,000	+21%	+$18.6K	﹤0.01%	265
2021 Q3	$107K	Buy	14,000 +3,000	+27%	+$25.4K	0.01%	244
2021 Q2	$107K	Hold	11,000	–	–	0.01%	251
2021 Q1	$91K	Sell	11,000 -1,200	-10%	-$12.7K	0.01%	239
2020 Q4	$83K	Buy	+12,200	New	+$98K	0.01%	225

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

InterOcean Capital Group's SRNE Position: Q1 2023 in Review

InterOcean Capital Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 17,000 shares — an estimated $15.1K sold.

InterOcean Capital Group first reported a position in SRNE in Q4 2020 and held it in 9 quarters. The position peaked at $107K in Q3 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

InterOcean Capital Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
InterOcean Capital Group sold 17,000 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $15.1K.
InterOcean Capital Group first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 9 quarters.
InterOcean Capital Group's Sorrento Therapeutics, Inc. position peaked at $107K in Q3 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on InterOcean Capital Group's 13F filing for Q1 2023, filed 15 May 2023.